Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Costello Syndrome | 8 | 2022 | 19 | 2.280 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2019 | 43 | 1.560 |
Why?
|
| Behavior Therapy | 4 | 2022 | 303 | 1.370 |
Why?
|
| Child Behavior Disorders | 3 | 2016 | 76 | 1.240 |
Why?
|
| Disorders of Sex Development | 6 | 2019 | 90 | 1.170 |
Why?
|
| Gender Identity | 4 | 2023 | 79 | 1.080 |
Why?
|
| Psychotherapy, Brief | 2 | 2019 | 49 | 0.990 |
Why?
|
| Transgender Persons | 2 | 2023 | 61 | 0.960 |
Why?
|
| Child Behavior | 2 | 2019 | 248 | 0.850 |
Why?
|
| Problem Behavior | 1 | 2022 | 38 | 0.800 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 242 | 0.670 |
Why?
|
| Hypothalamic Diseases | 1 | 2019 | 42 | 0.660 |
Why?
|
| Hamartoma | 1 | 2019 | 90 | 0.640 |
Why?
|
| Parenting | 2 | 2013 | 353 | 0.580 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2014 | 852 | 0.560 |
Why?
|
| Adaptation, Psychological | 4 | 2013 | 787 | 0.530 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2019 | 1401 | 0.440 |
Why?
|
| Abnormalities, Multiple | 5 | 2019 | 1023 | 0.440 |
Why?
|
| Verbal Learning | 1 | 2013 | 84 | 0.430 |
Why?
|
| Mothers | 1 | 2016 | 416 | 0.430 |
Why?
|
| Depressive Disorder | 1 | 2016 | 565 | 0.410 |
Why?
|
| Child Development | 1 | 2014 | 267 | 0.400 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 375 | 0.390 |
Why?
|
| Child | 24 | 2022 | 30546 | 0.390 |
Why?
|
| Cognition | 3 | 2009 | 969 | 0.390 |
Why?
|
| Parent-Child Relations | 1 | 2013 | 266 | 0.380 |
Why?
|
| Behavioral Symptoms | 1 | 2011 | 27 | 0.370 |
Why?
|
| Neuroimaging | 1 | 2014 | 402 | 0.370 |
Why?
|
| Models, Statistical | 1 | 2017 | 1185 | 0.370 |
Why?
|
| Stress, Psychological | 2 | 2014 | 1045 | 0.350 |
Why?
|
| Memory | 1 | 2013 | 445 | 0.340 |
Why?
|
| Child, Preschool | 16 | 2020 | 17048 | 0.330 |
Why?
|
| Behavior | 1 | 2009 | 100 | 0.330 |
Why?
|
| Cognition Disorders | 2 | 2014 | 762 | 0.330 |
Why?
|
| Parents | 4 | 2022 | 1084 | 0.330 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2013 | 96 | 0.320 |
Why?
|
| Syndrome | 4 | 2008 | 1407 | 0.310 |
Why?
|
| Polyhydramnios | 1 | 2007 | 51 | 0.300 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 346 | 0.300 |
Why?
|
| Neurocognitive Disorders | 2 | 2020 | 76 | 0.290 |
Why?
|
| Failure to Thrive | 1 | 2007 | 96 | 0.290 |
Why?
|
| Child Health Services | 1 | 2008 | 89 | 0.290 |
Why?
|
| Consensus | 1 | 2012 | 1105 | 0.280 |
Why?
|
| Adolescent | 19 | 2023 | 32743 | 0.270 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2018 | 43 | 0.270 |
Why?
|
| Depression | 1 | 2016 | 1733 | 0.270 |
Why?
|
| Urogenital Abnormalities | 2 | 2020 | 174 | 0.260 |
Why?
|
| Developmental Disabilities | 4 | 2020 | 697 | 0.250 |
Why?
|
| Anxiety Disorders | 1 | 2011 | 725 | 0.240 |
Why?
|
| Patient Care Team | 2 | 2016 | 822 | 0.240 |
Why?
|
| Patient Compliance | 4 | 2013 | 678 | 0.230 |
Why?
|
| Dwarfism | 2 | 2020 | 110 | 0.220 |
Why?
|
| Humans | 39 | 2023 | 270802 | 0.210 |
Why?
|
| Intellectual Disability | 2 | 2007 | 1065 | 0.210 |
Why?
|
| Social Stigma | 1 | 2023 | 74 | 0.200 |
Why?
|
| Sex Reassignment Procedures | 3 | 2017 | 19 | 0.200 |
Why?
|
| Noonan Syndrome | 1 | 2022 | 29 | 0.200 |
Why?
|
| Female | 25 | 2019 | 148967 | 0.190 |
Why?
|
| Terminology as Topic | 2 | 2017 | 417 | 0.190 |
Why?
|
| Decision Making | 1 | 2009 | 1251 | 0.190 |
Why?
|
| Hyperglycemia | 2 | 2014 | 337 | 0.190 |
Why?
|
| Male | 24 | 2020 | 128397 | 0.190 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 55 | 0.180 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 46 | 0.180 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 250 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 116 | 0.170 |
Why?
|
| Heart Defects, Congenital | 4 | 2019 | 1795 | 0.170 |
Why?
|
| Mental Health | 1 | 2023 | 415 | 0.170 |
Why?
|
| Puberty | 2 | 2016 | 97 | 0.160 |
Why?
|
| Phenotype | 6 | 2020 | 6516 | 0.160 |
Why?
|
| Sex Determination Processes | 1 | 2017 | 15 | 0.150 |
Why?
|
| Interdisciplinary Communication | 2 | 2017 | 272 | 0.150 |
Why?
|
| Medicaid | 1 | 2021 | 306 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 599 | 0.150 |
Why?
|
| Mythology | 1 | 2017 | 9 | 0.150 |
Why?
|
| Sex Counseling | 1 | 2017 | 16 | 0.140 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 24 | 0.130 |
Why?
|
| Intelligence Tests | 2 | 2007 | 88 | 0.130 |
Why?
|
| Turner Syndrome | 1 | 2016 | 65 | 0.130 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 85 | 0.130 |
Why?
|
| Comorbidity | 1 | 2022 | 2392 | 0.130 |
Why?
|
| Ectromelia | 1 | 2015 | 5 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 2057 | 0.130 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2015 | 34 | 0.130 |
Why?
|
| Anxiety | 1 | 2023 | 1236 | 0.130 |
Why?
|
| Sexual Development | 2 | 2019 | 23 | 0.120 |
Why?
|
| Social Behavior | 1 | 2017 | 310 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 130 | 0.120 |
Why?
|
| Genes, ras | 2 | 2008 | 679 | 0.120 |
Why?
|
| Encephalocele | 1 | 2015 | 59 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 336 | 0.110 |
Why?
|
| Infant | 6 | 2017 | 13989 | 0.110 |
Why?
|
| Language Tests | 1 | 2013 | 26 | 0.110 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 1145 | 0.110 |
Why?
|
| Young Adult | 6 | 2020 | 22225 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2018 | 1507 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 131 | 0.110 |
Why?
|
| Adult | 11 | 2020 | 81997 | 0.110 |
Why?
|
| Heart | 1 | 2019 | 1195 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 220 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2013 | 179 | 0.100 |
Why?
|
| Age of Onset | 1 | 2014 | 853 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2013 | 9474 | 0.100 |
Why?
|
| Family | 1 | 2016 | 784 | 0.100 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 6 | 0.100 |
Why?
|
| Endocrinology | 1 | 2014 | 155 | 0.100 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2013 | 160 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2017 | 8699 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2014 | 398 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 2394 | 0.090 |
Why?
|
| Germ-Line Mutation | 3 | 2019 | 1101 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2013 | 602 | 0.090 |
Why?
|
| Brain | 3 | 2019 | 4213 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 870 | 0.090 |
Why?
|
| Mutation | 4 | 2011 | 15911 | 0.080 |
Why?
|
| Manuals as Topic | 1 | 2009 | 18 | 0.080 |
Why?
|
| Vision, Ocular | 1 | 2009 | 135 | 0.080 |
Why?
|
| Facial Asymmetry | 1 | 2008 | 21 | 0.080 |
Why?
|
| Age Factors | 1 | 2017 | 5465 | 0.070 |
Why?
|
| United States | 4 | 2021 | 15855 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2009 | 427 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 5923 | 0.070 |
Why?
|
| Risk Factors | 5 | 2015 | 17900 | 0.070 |
Why?
|
| Pregnancy | 4 | 2018 | 8125 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 598 | 0.060 |
Why?
|
| Sex Factors | 1 | 2011 | 2184 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 712 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2008 | 256 | 0.060 |
Why?
|
| Pediatrics | 1 | 2014 | 1189 | 0.060 |
Why?
|
| Vocabulary | 1 | 2004 | 27 | 0.060 |
Why?
|
| Heterozygote | 1 | 2007 | 1056 | 0.060 |
Why?
|
| Texas | 2 | 2013 | 6447 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1486 | 0.060 |
Why?
|
| Face | 2 | 2019 | 252 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 239 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 885 | 0.050 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 610 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 920 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2008 | 931 | 0.050 |
Why?
|
| Mass Screening | 1 | 2011 | 1549 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 825 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1550 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 15212 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2021 | 83 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2013 | 33741 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 669 | 0.040 |
Why?
|
| Virilism | 1 | 2018 | 15 | 0.040 |
Why?
|
| Sex Preselection | 1 | 2017 | 8 | 0.040 |
Why?
|
| Gender Dysphoria | 1 | 2017 | 6 | 0.040 |
Why?
|
| Hormones | 1 | 2019 | 285 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2017 | 17 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 42 | 0.040 |
Why?
|
| ras Proteins | 1 | 2022 | 804 | 0.040 |
Why?
|
| Greece, Ancient | 1 | 2017 | 10 | 0.040 |
Why?
|
| Sex Reassignment Surgery | 1 | 2017 | 11 | 0.040 |
Why?
|
| History, Ancient | 1 | 2017 | 63 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 361 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2021 | 39832 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 4255 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 2016 | 66 | 0.030 |
Why?
|
| Genitalia | 1 | 2015 | 47 | 0.030 |
Why?
|
| Gonads | 1 | 2015 | 49 | 0.030 |
Why?
|
| Quality of Life | 1 | 2010 | 4775 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 419 | 0.030 |
Why?
|
| Fertility Preservation | 1 | 2016 | 151 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 150 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 2602 | 0.030 |
Why?
|
| Disclosure | 1 | 2015 | 180 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 1089 | 0.030 |
Why?
|
| Androgens | 1 | 2015 | 508 | 0.030 |
Why?
|
| Southwestern United States | 1 | 2011 | 60 | 0.020 |
Why?
|
| Informed Consent | 1 | 2015 | 416 | 0.020 |
Why?
|
| Estrogens | 1 | 2015 | 809 | 0.020 |
Why?
|
| Psychology | 1 | 2011 | 83 | 0.020 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2011 | 77 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 1250 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 118 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 1035 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 1271 | 0.020 |
Why?
|
| Family Relations | 1 | 2010 | 88 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 1301 | 0.020 |
Why?
|
| Pyloric Stenosis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 799 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2008 | 20 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 4134 | 0.020 |
Why?
|
| Farnesyltranstransferase | 1 | 2008 | 125 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 90 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 136 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 5778 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 7895 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 1265 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1252 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 2848 | 0.020 |
Why?
|
| Hospitalization | 1 | 2014 | 2168 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2363 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 12102 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 3402 | 0.010 |
Why?
|
| Caregivers | 1 | 2010 | 753 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 5060 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 5171 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 2357 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 4963 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 13021 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 5437 | 0.010 |
Why?
|
| Neoplasms | 3 | 2015 | 15919 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 6768 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 1946 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 6193 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 7784 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 90347 | 0.010 |
Why?
|